| Income statement (USD) | Q4 2026 ended Jun 30, 2026 | Q3 2026 ended Mar 31, 2026 | Q2 2026 ended Dec 31, 2025 | Q1 2026 ended Sep 30, 2025 | Q4 2025 ended Jun 30, 2025 | Q3 2025 ended Mar 31, 2025 | Q2 2025 ended Dec 31, 2024 | Q1 2025 ended Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 21.20B | 21.23B | 22.21B | 22.39B | 20.89B | 19.78B | 21.88B | 21.74B |
| Cost of revenue | 10.92B | 10.72B | 10.83B | 10.89B | 10.63B | 9.69B | 10.42B | 10.42B |
| Gross profit | 10.28B | 10.51B | 11.37B | 11.50B | 10.26B | 10.08B | 11.46B | 11.32B |
| Selling, general and admin | 6.33B | 5.94B | 6.01B | 5.64B | 5.90B | 5.52B | 5.72B | 5.52B |
| Operating income | 3.95B | 4.58B | 5.37B | 5.86B | 4.36B | 4.56B | 5.74B | 5.80B |
| EBITDA | 4.76B | 5.36B | 6.17B | 6.62B | 5.08B | 5.25B | 6.45B | 6.53B |
| Interest expense | 236.00M | 223.00M | 220.00M | 197.00M | 212.00M | 217.00M | 240.00M | 238.00M |
| Income tax | 852.00M | 1.04B | 1.09B | 1.25B | 895.00M | 868.00M | 1.19B | 1.15B |
| Net income | 3.04B | 3.93B | 4.32B | 4.75B | 3.62B | 3.77B | 4.63B | 3.96B |
| EPS | 1.28 | 1.66 | 1.82 | 2.00 | 1.51 | 1.58 | 1.94 | 1.65 |
| EPS (diluted) | 1.26 | 1.63 | 1.78 | 1.95 | 1.48 | 1.54 | 1.88 | 1.61 |
| Diluted shares | -3.30M | 2.42B | 2.42B | 2.44B | -3.60M | 2.45B | 2.46B | 2.47B |
| Dividends per share | 1.09 | 1.06 | 1.06 | 1.06 | 1.06 | 1.01 | 1.01 | 1.01 |
From Procter & Gamble's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.